Sitter, T <br/><br/>
Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.  [electronic resource] 

 -  Kidney international  Jan 1999 
 - 120-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0085-2538 
<br/><br/><label>Standard No.: </label>10.1046/j.1523-1755.1999.00244.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies--pharmacology<br/>Biological Transport, Active<br/>Carrier Proteins--pharmacology<br/>Cells, Cultured<br/>Chloroquine--pharmacology<br/>Culture Media, Conditioned<br/>Epithelial Cells--drug effects<br/>Fibrinolysis--physiology<br/>Gene Expression<br/>Glutathione Transferase--pharmacology<br/>Humans<br/>Iodine Radioisotopes<br/>Lectins, C-Type<br/>Low Density Lipoprotein Receptor-Related Protein-1<br/>Mannose Receptor<br/>Mannose-Binding Lectins<br/>Plasminogen Activator Inhibitor 1--biosynthesis<br/>RNA, Messenger--genetics<br/>Receptors, Cell Surface--antagonists & inhibitors<br/>Receptors, Immunologic--genetics<br/>Receptors, LDL--genetics<br/>Receptors, Urokinase Plasminogen Activator<br/>Recombinant Fusion Proteins--pharmacology<br/>Tissue Plasminogen Activator--biosynthesis<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>Urokinase-Type Plasminogen Activator--metabolism